Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

ClinicalTrials.gov ID: NCT00295165

Public ClinicalTrials.gov record NCT00295165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Phase 3 Induction Study to Assess the Efficacy and Safety of 6µg Sargramostim (Leukine) Administered Subcutaneously Once Daily for 8 Weeks in Patients With Active Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate if Leukine can induce clinical response or remission in patients with Crohn's disease.

Study identification

NCT ID
NCT00295165
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
33 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Oct 2006 (Actual)
Completion
Oct 2006 (Actual)
Last update posted
Dec 4, 2013

2006

United States locations

U.S. sites
47
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Orange California 92868 —
Not listed San Francisco California 94117 —
Not listed Lakewood Colorado 80215 —
Not listed Littleton Colorado 80120 —
Not listed Washington D.C. District of Columbia 20007-2197 —
Not listed Boca Raton Florida 33486 —
Not listed Gainesville Florida 32610-0254 —
Not listed Atlanta Georgia 30342 —
Not listed Indianapolis Indiana 46202 —
Not listed Lexington Kentucky 40536 —
Not listed Louisville Kentucky 40202 —
Not listed Hagerstown Maryland 21740 —
Not listed Lutherville Maryland 21093 —
Not listed Towson Maryland 21204 —
Not listed Ann Arbor Michigan 48109-0330 —
Not listed Chesterfield Michigan 48047 —
Not listed Troy Michigan 48098 —
Not listed Plymouth Minnesota 55446 —
Not listed Mexico Missouri 65265 —
Not listed St Louis Missouri 63110 —
Not listed Lincoln Nebraska 68503 —
Not listed Florham Park New Jersey 07932 —
Not listed New Brunswick New Jersey 08901 —
Not listed Great Neck New York 11021 —
Not listed Mineola New York 11501-3987 —
Not listed New York New York 10028 —
Not listed Syracuse New York 13210 —
Not listed Charlotte North Carolina 28207 —
Not listed Raleigh North Carolina 27612 —
Not listed Winston-Salem North Carolina 27157 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45242 —
Not listed Cleveland Ohio 44195 —
Not listed Dayton Ohio 45440 —
Not listed Oklahoma City Oklahoma 73104 —
Not listed Tulsa Oklahoma 74104 —
Not listed Sayre Pennsylvania 18840 —
Not listed Columbia South Carolina 29203 —
Not listed San Antonio Texas 78229 —
Not listed Charlottesville Virginia 22908 —
Not listed Chesapeake Virginia 23320 —
Not listed Christiansburg Virginia 24073 —
Not listed Norfolk Virginia 23502 —
Not listed Richmond Virginia 23249-0002 —
Not listed Seattle Washington 98195 —
Not listed Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00295165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00295165 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →